protein kinase D1 |
HYDROXYPROGESTERONE |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, theta |
HYDROXYPROGESTERONE |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, epsilon |
HYDROXYPROGESTERONE |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, gamma |
HYDROXYPROGESTERONE |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
HYDROXYPROGESTERONE |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, iota |
FLUNARIZINE |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, beta 1 |
FLUNARIZINE |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, delta |
FLUNARIZINE |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, mu |
FLUNARIZINE |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
nitric oxide synthase 2, inducible |
PARAQUAT DICHLORIDE |
Nitric Oxide Synthase, Inducible (iNOS) |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 5 |
HEXACHLOROPHENE |
Muscarinic M5 |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 1 |
HEXACHLOROPHENE |
Muscarinic M1 |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 1 |
NAFENOPIN |
Muscarinic M1 |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
BUPROPION |
Glutamate, NMDA, Agonism |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, NMDA2C |
BUPROPION |
Glutamate, NMDA, Agonism |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
BUPROPION |
Glutamate, NMDA, Agonism |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
BUPROPION |
Glutamate, NMDA, Agonism |
-20% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
BUPROPION |
Glutamate, NMDA, Agonism |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
BUPROPION |
Glutamate, NMDA, Agonism |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 14 |
TEICOPLANIN |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
TEICOPLANIN |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
FENBENDAZOLE |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
FENBENDAZOLE |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
FENBENDAZOLE |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
acetylcholinesterase (YT blood group) |
RIFAPENTINE |
Acetylcholinesterase |
-20% |
NoneNone |
NoneNone |
View
|
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
RIFAPENTINE |
Acetylcholinesterase |
-20% |
NoneNone |
NoneNone |
View
|
acetylcholinesterase |
RIFAPENTINE |
Acetylcholinesterase |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 1 |
AMITRAZ |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
AMITRAZ |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel associated protein 1 |
3,3',4',5-TETRACHLOROSALICYLANILIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel associated protein 2 |
3,3',4',5-TETRACHLOROSALICYLANILIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
3,3',4',5-TETRACHLOROSALICYLANILIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
3,3',4',5-TETRACHLOROSALICYLANILIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IX, alpha |
3,3',4',5-TETRACHLOROSALICYLANILIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VII, alpha |
3,3',4',5-TETRACHLOROSALICYLANILIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
amiloride-sensitive cation channel 5, intestinal |
3,3',4',5-TETRACHLOROSALICYLANILIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
TERBINAFINE |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
TERBINAFINE |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
TICLOPIDINE |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
TICLOPIDINE |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
TOLMETIN |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
TOLMETIN |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
MECLOFENAMIC ACID |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
MECLOFENAMIC ACID |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
METHYLPARABEN |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
METHYLPARABEN |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
PRAZIQUANTEL |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
PRAZIQUANTEL |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
QUETIAPINE |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
ALPRAZOLAM |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
ALPRAZOLAM |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
CHLOROXYLENOL |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
CHLOROXYLENOL |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
GENTIAN VIOLET |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
GENTIAN VIOLET |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2C19 monooxygenase |
METHYLPARABEN |
CYP450-2C19 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2C19 monooxygenase |
OXYQUINOLINE |
CYP450-2C19 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2C19 monooxygenase |
CLORPRENALINE |
CYP450-2C19 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2C19 monooxygenase |
PROGLUMIDE |
CYP450-2C19 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 |
METHYL SALICYLATE |
Adenosine Transporter |
-20% |
NoneNone |
NoneNone |
View
|
concentrative Na+ nucleoside cotransporter (DBSS) |
METHYL SALICYLATE |
Adenosine Transporter |
-20% |
NoneNone |
NoneNone |
View
|
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
METHYL SALICYLATE |
Adenosine Transporter |
-20% |
NoneNone |
NoneNone |
View
|
adenine nucleotide translocase (DBSS) (Non-specific probe) |
METHYL SALICYLATE |
Adenosine Transporter |
-20% |
NoneNone |
NoneNone |
View
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
METHYL SALICYLATE |
Adenosine Transporter |
-20% |
NoneNone |
NoneNone |
View
|
adenosine A2a receptor |
FLUNARIZINE |
Adenosine A2A |
-20% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 4 polypeptide |
ANIRACETAM |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
ANIRACETAM |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
ANIRACETAM |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
ANIRACETAM |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
ANIRACETAM |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, beta 3 polypeptide |
ANIRACETAM |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, beta 2 polypeptide |
ANIRACETAM |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
ATPase, (Na+)/K+ transporting, beta 4 polypeptide |
ANIRACETAM |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
ZINC CHLORIDE |
Dopamine Transporter |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
TRICHLOROACETIC ACID |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
TRICHLOROACETIC ACID |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
ZINC CHLORIDE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
ZINC CHLORIDE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
AZARIBINE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
AZARIBINE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
NAFENOPIN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
NAFENOPIN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
PARAQUAT DICHLORIDE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
PARAQUAT DICHLORIDE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
BROMOBENZENE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
BROMOBENZENE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 |
MANGANESE (II) CHLORIDE |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
MANGANESE (II) CHLORIDE |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 3, subfamily a, polypeptide 13 |
PROSCILLARIDIN |
CYP450-3A4 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
BROMFENAC |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
BROMFENAC |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
natriuretic peptide receptor 2 |
BETA-NAPHTHOFLAVONE |
Atrial Natriuretic Factor (ANF) |
-20% |
NoneNone |
NoneNone |
View
|
guanylate cyclase A/atrial natriuretic peptide receptor (Non-specific probe) |
BETA-NAPHTHOFLAVONE |
Atrial Natriuretic Factor (ANF) |
-20% |
NoneNone |
NoneNone |
View
|
natriuretic peptide receptor 3 |
BETA-NAPHTHOFLAVONE |
Atrial Natriuretic Factor (ANF) |
-20% |
NoneNone |
NoneNone |
View
|
bradykinin receptor, beta 2 |
SULOCTIDIL |
Bradykinin B2 |
-20% |
NoneNone |
NoneNone |
View
|
bradykinin receptor B2 |
SULOCTIDIL |
Bradykinin B2 |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2C19 monooxygenase |
CYCLANDELATE |
CYP450-2C19 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
adenosine A2a receptor |
SULOCTIDIL |
Adenosine A2A |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
ERGOCALCIFEROL |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
HYDROXYPROGESTERONE |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
MONTELUKAST |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
NYSTATIN |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
TERFENADINE |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
VINDESINE |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
ZAFIRLUKAST |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
ALFACALCIDOL |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
ACLARUBICIN |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
PROSCILLARIDIN |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 |
GLUTATHIONE, OXIDIZED FORM |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
GLUTATHIONE, OXIDIZED FORM |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
NYSTATIN |
Serotonin Transporter |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3a |
MONTELUKAST |
Serotonin 5-HT3 |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3b |
MONTELUKAST |
Serotonin 5-HT3 |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3a |
SULFAMERAZINE |
Serotonin 5-HT3 |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3b |
SULFAMERAZINE |
Serotonin 5-HT3 |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3a |
4-NONYLPHENOL |
Serotonin 5-HT3 |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3b |
4-NONYLPHENOL |
Serotonin 5-HT3 |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
STRONTIUM CHLORIDE HEXAHYDRATE |
Serotonin 5-HT2C |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 1A |
EPINEPHRINE |
Serotonin 5-HT1A |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 1A |
4-NONYLPHENOL |
Serotonin 5-HT1A |
-20% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 1 |
HYDROXYPROGESTERONE |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 7 |
HYDROXYPROGESTERONE |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X-like 1, orphan receptor |
HYDROXYPROGESTERONE |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
DIMENHYDRINATE |
Protein Tyrosine Kinase, HER2 Receptor |
-20% |
NoneNone |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
DIMENHYDRINATE |
Protein Tyrosine Kinase, HER2 Receptor |
-20% |
NoneNone |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
GLYCINE |
Protein Tyrosine Kinase, HER2 Receptor |
-20% |
NoneNone |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
GLYCINE |
Protein Tyrosine Kinase, HER2 Receptor |
-20% |
NoneNone |
NoneNone |
View
|
acetylcholinesterase (YT blood group) |
NYSTATIN |
Acetylcholinesterase |
-20% |
NoneNone |
NoneNone |
View
|
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
NYSTATIN |
Acetylcholinesterase |
-20% |
NoneNone |
NoneNone |
View
|
acetylcholinesterase |
NYSTATIN |
Acetylcholinesterase |
-20% |
NoneNone |
NoneNone |
View
|
endothelin receptor type A |
BERBERINE CHLORIDE |
Endothelin ETA |
-20% |
NoneNone |
NoneNone |
View
|
cannabinoid receptor 1 (brain) |
BUFLOMEDIL |
Cannabinoid CB1 |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
RIFAPENTINE |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 3 |
3,3',4',5-TETRACHLOROSALICYLANILIDE |
Muscarinic M3 |
-20% |
NoneNone |
NoneNone |
View
|
histamine receptor H 2 |
BITHIONOL |
Histamine H2 |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
PIPERILATE ETHOBROMIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
PIPERILATE ETHOBROMIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
PIPERILATE ETHOBROMIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
PIPERILATE ETHOBROMIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
PIPERILATE ETHOBROMIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
PIPERILATE ETHOBROMIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
PIPERILATE ETHOBROMIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
PIPERILATE ETHOBROMIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
PIPERILATE ETHOBROMIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
PIPERILATE ETHOBROMIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
PIPERILATE ETHOBROMIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
PIPERILATE ETHOBROMIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
PIPERILATE ETHOBROMIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
PIPERILATE ETHOBROMIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
PIPERILATE ETHOBROMIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
PIPERILATE ETHOBROMIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
PIPERILATE ETHOBROMIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
PIPERILATE ETHOBROMIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
PIPERILATE ETHOBROMIDE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
SULFAMETHAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
SULFAMETHAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
SULFAMETHAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
SULFAMETHAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
SULFAMETHAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
SULFAMETHAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
SULFAMETHAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
SULFAMETHAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
SULFAMETHAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
SULFAMETHAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
SULFAMETHAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
SULFAMERAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
SULFAMERAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
SULFAMERAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
SULFAMERAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
SULFAMERAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
SULFAMERAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
SULFAMERAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
SULFAMERAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
SULFAMERAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
SULFAMERAZINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 3, subfamily a, polypeptide 13 |
ANDROSTERONE |
CYP450-3A4 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
CILOSTAZOL |
Potassium Channel HERG |
-20% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H, member 8 |
CILOSTAZOL |
Potassium Channel HERG |
-20% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 6 |
CILOSTAZOL |
Potassium Channel HERG |
-20% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 7 |
CILOSTAZOL |
Potassium Channel HERG |
-20% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
CILOSTAZOL |
Potassium Channel HERG |
-20% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 5 |
CILOSTAZOL |
Potassium Channel HERG |
-20% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 3 |
CILOSTAZOL |
Potassium Channel HERG |
-20% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 4 |
CILOSTAZOL |
Potassium Channel HERG |
-20% |
NoneNone |
NoneNone |
View
|
potassium voltage-gated channel, subfamily H (eag-related), member 1 |
CILOSTAZOL |
Potassium Channel HERG |
-20% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 3, subfamily a, polypeptide 13 |
MEGESTROL ACETATE |
CYP450-3A4 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 4 |
COBALT (II) CHLORIDE |
Chemokine CCR4 |
-20% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
TRANS-PLATINUM(II)DIAMMINE DICHLORIDE |
Adrenergic, Norepinephrine Transporter |
-20% |
NoneNone |
NoneNone |
View
|
nitric oxide synthase 2A (inducible, hepatocytes) |
TRANS-PLATINUM(II)DIAMMINE DICHLORIDE |
Nitric Oxide Synthase, Inducible (iNOS) |
-20% |
NoneNone |
NoneNone |
View
|
nitric oxide synthase 2, inducible |
TRANS-PLATINUM(II)DIAMMINE DICHLORIDE |
Nitric Oxide Synthase, Inducible (iNOS) |
-20% |
NoneNone |
NoneNone |
View
|
nitric oxide synthase 2A (inducible, hepatocytes) |
2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN |
Nitric Oxide Synthase, Inducible (iNOS) |
-20% |
NoneNone |
NoneNone |
View
|
nitric oxide synthase 2, inducible |
2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN |
Nitric Oxide Synthase, Inducible (iNOS) |
-20% |
NoneNone |
NoneNone |
View
|
arachidonate 15-lipoxygenase, second type |
2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN |
Lipoxygenase 15-LO |
-20% |
NoneNone |
NoneNone |
View
|
arachidonate 15-lipoxygenase |
2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN |
Lipoxygenase 15-LO |
-20% |
NoneNone |
NoneNone |
View
|
arachidonate 15-lipoxygenase |
2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN |
Lipoxygenase 15-LO |
-20% |
NoneNone |
NoneNone |
View
|
protein phosphatase 3 (formerly 2B), catalytic subunit, alpha isoform (calcineurin A alpha) |
2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-20% |
NoneNone |
NoneNone |
View
|
protein phosphatase 3 (formerly 2B), catalytic subunit, beta isoform (calcineurin A beta) |
2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-20% |
NoneNone |
NoneNone |
View
|
protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma) |
2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-20% |
NoneNone |
NoneNone |
View
|
protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma) |
2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-20% |
NoneNone |
NoneNone |
View
|
protein phosphatase 3, catalytic subunit, beta isoform |
2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-20% |
NoneNone |
NoneNone |
View
|